interferon beta-1a

FDA Drug Profile — AVONEX, Rebif, REBIF

Drug Details

Generic Name
interferon beta-1a
Brand Names
AVONEX, Rebif, REBIF
Application Number
BLA103628
Sponsor
Biogen Inc.
NDC Codes
5
Dosage Forms
KIT, LIQUID, INJECTION, SOLUTION
Routes
INTRAMUSCULAR, SUBCUTANEOUS
Active Ingredients
INTERFERON BETA-1A

Indications and Usage

1 INDICATIONS AND USAGE REBIF is indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. Rebif is an interferon beta indicated for the treatment of relapsing forms of multiple sclerosis (MS), to include clinically isolated syndrome, relapsing-remitting disease, and active secondary progressive disease, in adults. ( 1 )